Status:
RECRUITING
Goal Management Training (GMT) for Improvement of Cognitive Control Function After Acquired Brain Injury
Lead Sponsor:
St. Olavs Hospital
Collaborating Sponsors:
Norwegian University of Science and Technology
Conditions:
Acquired Brain Injury
Executive Function Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to investigate predictors of treatment outcome, and the effect of individual treatment components of Goal Management Training (GMT) for improvement of cognitive cont...
Detailed Description
The Global Executive Composite (GEC) score derived from BRIEF-A will be used as the primary outcome measure. A selection of other included measures will be used as secondary outcome measures. Data wil...
Eligibility Criteria
Inclusion
- Patients aged 18-65 with acquired brain injury with no concomitant diseases minimum 12 months' post-injury/surgery, reporting cognitive control problems by structured interview or clinical performance measures.
Exclusion
- Non-fluency in Norwegian Language
- Major psychiatric disorder or reported ongoing alcohol or substance abuse.
- Premorbid neurological disease or insult and/or comorbid neurological disease.
- Aphasia or other specified language problems causing potential communication problems.
- Impaired basic linguistic, mnemonic, motor, or perceptual function that can interfere with the ability to engage with training or estimated IQ \< 85
Key Trial Info
Start Date :
September 26 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2030
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT06604000
Start Date
September 26 2023
End Date
January 1 2030
Last Update
December 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Olavs Hospital
Trondheim, Norway, 7030